Countouriotis Athena bought PASG
May 19, 2026 · Form 4 insider transaction
Countouriotis Athena bought 10,539 shares of Passage Bio, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
10,539
Price
$0.00
Total value
N/A
InsiderCountouriotis Athena
Role—
CompanyPassage Bio, Inc. (PASG)
SecurityDirector Stock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateMay 19, 2026
Filing dateMay 21, 2026
Shares owned after10,539
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The stock option vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2027 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date.